Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

CombiGene AB (LARK) Income Statement

0 Followers

CombiGene AB Income Statement

Last quarter (Q2 2026), CombiGene AB's total revenue was kr50.00K, an increase of 142.02% from the same quarter last year. In Q2, CombiGene AB's net income was kr610.50K. See CombiGene AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
kr 0.00kr 326.00Kkr 5.54Mkr 26.70Mkr 84.04M
kr -8.16Mkr -46.78Mkr -21.29Mkr -19.20Mkr 15.16M
kr 4.81Mkr 31.25Mkr 18.77Mkr 3.11Mkr 15.59M
Depreciation and Amortizationkr 5.79Mkr 4.07Mkr 329.34Kkr 300.00Kkr 2.59M
kr -7.19Mkr -43.15Mkr -35.98Mkr -5.86Mkr 23.56M
kr -12.98Mkr -47.22Mkr -38.60Mkr -6.95Mkr 20.96M
kr 617.00Kkr 2.34Mkr 2.94Mkr 790.14Kkr 24.00
kr -12.36Mkr -44.88Mkr -35.66Mkr -6.16Mkr 20.96M
kr -12.36Mkr -44.88Mkr -35.66Mkr -6.16Mkr 20.96M
Per Share Metrics
Basic EPSkr -0.62kr -2.27kr -1.80kr -0.31kr 1.21
Diluted EPSkr -0.62kr -2.27kr -1.80kr -0.31kr 1.21
Weighted Average Shares Outstanding19.80M19.80M19.80M19.80M17.31M
Weighted Average Shares Outstanding (Diluted)19.80M19.80M19.80M19.80M17.31M

Currency in SEK

CombiGene AB Earnings and Revenue History

-60M060M120M-200000 %-100000 %0 %100000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin